Molecular monitoring of complete cytogenetic responders following treatment with imatinib (STI571, Gleevec) for CML: A report from the UKSTI571 study group.

Liang Feng, M. W. Drummond, J. Byrne, P. C. A. Shepherd, J. F. Apperley, S. G. O'Brien, C. F. Craddock, R. E. Clark, F. Cervantes, A. L. Lennard, T. L. Holyoake, R. M. Szydlo, J. M. Goldman, J. S. Kaeda

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)368A-368A
Issue number11
Publication statusPublished - 2002

Cite this